Biofeedback therapy (BFT) can be unsuccessful in constipated patients, even those with pelvic floor dysfunction. Electrical stimulation therapy (EST) has been introduced as a novel therapeutic modality in patients with chronic constipation, especially those who have rectal hyposensitivity. We evaluated the efficacy of EST based on five years' clinical experience. 
Introduction
Electrical stimulation therapy (EST) of the gastrointestinal tract has been used to treat gastric motor dysfunction since 1963. 1, 2 EST in the colon may be an alternative to conventional treatments, such as biofeedback, and surgery. [3] [4] [5] Most EST procedures of the colon, such as sacral nerve stimulation and intramural stimulation, are regarded as invasive. 3 EST using an anal plug is a non-invasive method having been used to treat urinary incontinence since the 1970s. 6 As EST may rehabilitate the pelvic floor muscle, it has been tested in defecation disorders. EST using an anal plug has been shown successful in up to 60% of patients with fecal incontinence. 7, 8 EST using an anal plug has been found as effective as conventional biofeedback treatment in patients with rectal hyposensitivity (RH). 4, 5 This method has also been used to treat patients with functional constipation, regardless of RH, including patients refractory to conventional biofeedback therapy. 9 We have therefore assessed the effect of EST in patients with chronic constipation and compared EST with BFT. We also performed multivariate analysis to determine factors prognostic of successful treatment with EST.
M aterials and M ethods

Patients
Patients with chronic functional defecatory disorder who visited Asan Medical Center, Seoul, Korea, between January 2002 and February 2007 were enrolled. Indications for EST included patients diagnosed with functional defecatory disorder who failed to respond to conventional biofeedback therapy. Most of these patients had first been treated with medication, and patients diagnosed by ROME II or who had pelvic floor dyssynergia (PFD) were indicated for BFT. PFD was diagnosed by anorectal manometry, balloon expulsion test, defecography, and colon transit time study. ROME II criteria for PFD included inappropriate contraction or failure to relax the pelvic floor muscles during repeated attempts to defecate. All enrolled patients satisfied ROME II criteria. 10 Organic diseases were excluded by colonoscopy or barium enema. Patients with a history of diabetes mellitus, hypothyroidism, psychiatric disturbance, previous history of intestinal surgery, or drug abuse were excluded. Patients with slow transit time alone, another subtype of chronic constipation, were also excluded, but patients with both slow transit time and PFD were included. Patients with a pacemaker or implantable cardioverter-defibrillator were excluded, as were patients with a history of current or recent anal bleeding. Loss of follow-up was defined when patients who had undergone EST once did not undergo subsequent EST sessions regardless of patients' will. This retrospective analysis was approved by institutional review board of Asan Medical Center.
Definition of Pelvic Floor Dyssynergia and Rectal Hyposensitivity
Patients, who met the diagnostic criteria of ROME II, were diagnosed with PFD if they had dyssynergia on anorectal manometry and an inability to expel a 50 mL water filled balloon in 5 minutes. Rectal hyposensitivity (RH) was defined as the point when the patient could no longer feel any sensation of a desire to defecate in spite of the balloon being inflated up to 80 mL and when more than 90 mL of air inflation was needed to feel a sensation of a desire to defecate, which is currently the cut-off value at our institution.
Anorectal Manometry
Before enrollment, all patients underwent anorectal manometry to determine the cause of chronic constipation. All standard procedures were performed by one experienced nurse, and PFD was diagnosed by interpreting pressure curves during the bearing down phase. Manometry was performed using a stationary pull through technique with a microcapillary infusion system, Zinetic polyvinyl catheters (Medtronic, Denmark) and Polygramnet software (Medtronic, Denmark).
Balloon Expulsion Test
Following anorectal manometry, all patients were told to expel a 50 mL adult anorectal latex water-filled balloon. Five minutes of straining were allowed, after of which 'failure of balloon expulsion' was diagnosed.
Colon Transit Time Study
For the colon transit time (CTT) measurement, we used capsules of hardened gelatine filled with barium-impregnated polyethylene markers (pellets). Seven days before examination, any kind of medications and enemas that could influence the examination results were stopped. A Sitzmarker capsule containing 24 radiopaque, 1-to 2-mm thick rings (Sitzmarker, Lafayette Pharmaceutical, Inc, Forth Worth, TX, USA) was taken one per each day for 3 days. On the fourth day, simple erect film was checked. CTTS was measured following the previously published method. 11 Usually in normal CTT, at least 80% of the markers should be passed spontaneously by the fifth day, and all markers should be expelled by the seventh day. Pelvic retention of the markers is consistent with pelvic outlet obstruction, whereas diffuse scatter is more consistent with colonic inertia.
Electrical Stimulation Therapy
EST was performed using a computer with software, an electrical generator, a monitor, and an anal plug (Kontinence Clinical HMT 2000; HMT, Seoul, Korea), with all procedures performed by one well-trained, experienced nurse. Each EST session took 24 minutes, with 12 sessions per 2-week cycle. In each session, an anal plug was inserted into the patient's anus. Stimulatory parameters included a pulse width of 360-960 μsec, a frequency of 2-110 Hz, and an amplitude of 30-35 V with the voltage adjusted to each patient's threshold of electrical pain sense. The clinical HMT 2000 could provide a variant mode, which was developed to overcome methodical limits and avoid problems such as discomfort and muscle fatigue. The main characteristics of variant mode were optimization of the stimulation waveform, synchronization to adjust energy, and automatic energy control by the structure of the double channel electrodes. 12 
Indications of Electrical Stimulation Therapy
We hypothesized the indications for EST as follows: patients who are refractory to biofeedback therapy, and patients who have rectal hyposensitivity.
Study Design: Protocols
Before EST, patients underwent CTT study, anorectal manometry (ARM) and balloon expulsion tests (BET). After EST, patients again underwent ARM and BET to define the differences in objective parameters after the therapy. Before and after EST, all enrolled patients completed questionnaires addressing subjective parameters during defecation, including overall satisfaction, straining, feelings of incomplete evacuation, and feelings of obstruction. Overall satisfaction was graded from 0 (very unsatisfactory) to 10 (very satisfactory); other subjective parameters were scored from 0 (absent) to 10 (very severe). Each patient's response to EST was recorded upon the last session of EST and scored as yes or no. Treatment outcome was assessed as responsive or non-responsive, based on the results of symptom questionnaires. EST was defined as achieving a good response when at least a two point improvement was seen in the global defecatory satisfactory score compared with the score prior to EST.
Statistical Methods
Assessment of treatment efficacy was analyzed at the end of each session. All statistical analyses were performed using SPSS version 13.0 (SPSS Inc., Illinois, USA). The Mann-Whitney U test and the Wilcoxon rank sum test were used to analyze continuous parameters, while the Chi-square test was used to analyze non-continuous parameters. 
Results
Demographic Results
A total of 159 patients (62 male, 97 female; mean age ± SD, 53 ± 17 years) underwent EST since 2002. EST was successful in 87 patients (33 males, 54 females; mean age ± SD, 50 ± 17 years) and unsuccessful in 60 patients (28 males, 32 females, mean age ± SD, 55 ± 17 years), whereas 12 patients (5 males, 7 females, mean age ± SD, 55 ± 17 years) dropped out. Of the total cohort, 4 patients underwent more than one cycle of EST, with 1 undergoing 7 cycles (Fig. 1) .
By intention-to-treat (ITT) analysis, the success rate of EST might be estimated as 54.7% (87/159), while by per-protocol analysis, the success rate was 59.2% (87/147).
EST was done using an anorectal probe with pulse generator (Fig. 2) .
Indication of Electrical Stimulation Therapy
The indications for EST were functional constipation refractory to BFT without RH (88 patients, 29 males, 59 females; mean age ± SD, 49 ± 17 years) and those with RH (59 patients, 32 males, 27 females; mean age ± SD, 54 ± 17 years).
Subjective and Objective Parameters: Overall Results
Pretreatment results
Pretreatment subjective parameter (Table 1) and objective  (Table 2 ) parameters, including anorectal manometry, did not differ significantly between the EST-responsive and non-responsive groups.
Changes in Subjective and Objective Parameters
In the EST-responsive group, overall satisfaction improved significantly (from 7.3 ± 3.0 to 4.3 ± 2.5, P ＜ 0.05), as did other subjective parameters, including feeling of incomplete evacuation, straining, and feeling of obstruction (P ＜ 0.05) ( Table 3 ). In addition, objective parameters, such as resting anal sphincter pressure, also decreased significantly (P ＜ 0.05) ( Table 4) . When we compared the EST-responsive and non-responsive groups, the only significant difference in characteristics was maximum volume of sense (152 ± 50 mmHg vs. 179 ± 62 mmHg, P ＜ 0.05).
Factors That Affect the Effectiveness of Electrical Stimulation Therapy
When we analyzed the factors that may influence the effect of EST, including underlying disease, CTT results, subjective pa- rameters, and anorectal manometric results, we found that none was significant when comparing the EST-responsive and non-responsive groups (Table 1, 2 and 5) . Of the underlying diseases tested, such as diabetes mellitus, hypertension, neurologic disorders, psychiatric disorders, benign prostate hyperplasia, and hypothyroidism, none predicted response to EST (data not shown).
Subgroup Analysis
Refractory to biofeedback therapy
Of the 88 patients refractory to BFT, 57 (64.8%) responded to EST. Of the subjective and objective parameters assessed, none changed significantly between patients responsive and non-responsive to EST except for satisfaction score (3.8 ± 2.1 vs. 6.7 ± 3.5, P ＜ 0.05). There were no differences between responsive and non-responsive patients in analysis of CTT (P ＞ 0.05 by Fisher's exact test).
Rectal hyposensitivity
Of the 59 RH patients, 30 (50.8%) showed improvement after EST (Table 6 ). Patients responsive to EST showed significant improvements in desire to defecate volume (DDV; from 115.0 ± 17.9 mL to 80.0 ± 45.6 mL, P ＜ 0.05), urge to defecate volume (UDV; from 178.2 ± 50.7 mL to 153.6 ± 58.0 mL, P ＜ 0.05), and maximum tolerable volume (MTV; from 198.3 ± 35.1 to 173.3 ± 37.3 in MTV, P ＜ 0.05) ( Table 7) .
When we compared the 30 responders and 29 non-responders to EST, there were no significant differences in the analysis of CTT (P ＞ 0.05 by Fisher's exact test) (data not shown). 
Adverse Effects of Electrical Stimulation Therapy
Only 2 patients showed anal bleeding during the insertion of the anal plug. The nature of bleeding was oozing. It stopped immediately after the removal of the plug. Both of these patients had hemorrhoids, which could be the reason for the bleeding.
We found no changes in objective parameters in the overall patient group and in the subgroup of patients refractory to BFT, except for the subgroup of RH patients. In the latter, objective parameters, including DDV and MTV, were improved after treatment. When we analyzed subjective parameters in the overall patient EST group and subgroups, we found no characteristic that predicted responsiveness to EST.
In conclusion, we found that EST was successful in the treatment of patients with chronic functional constipation refractory to BFT, RH, and anal pain. Factors predictive of responsiveness to EST could not be determined, suggesting the need for additional studies of this modality.
